NCM
ABEO icon

Nantahala Capital Management’s Abeona Therapeutics ABEO Stock Holding History

Nantahala Capital Management’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.7M Buy
5,136,490
+123,438
+2% +$678K 1.05% 22
2026
Q1 		$22.5M Buy
5,013,052
+50,000
+1% +$250K 0.83% 33
2025
Q4 		$26.2M Buy
4,963,052
+398,387
+9% +$2.01M 0.86% 26
2025
Q3 		$24.1M Buy
4,564,665
+195,000
+4% +$1.24M 0.84% 25
2025
Q2 		$24.8M Buy
4,369,665
+859,815
+24% +$4.89M 0.97% 18
2025
Q1 		$16.7M Sell
3,509,850
-19,364
-0.5% -$105K 0.66% 25
2024
Q4 		$19.7M Buy
3,529,214
+96,577
+3% +$594K 0.84% 24
2024
Q3 		$21.7M Sell
3,432,637
-37,400
-1% -$195K 1.1% 21
2024
Q2 		$14.7M Buy
3,470,037
+1,159,397
+50% +$5.91M 0.86% 21
2024
Q1 		$16.8M Buy
2,310,640
+60,388
+3% +$383K 0.96% 21
2023
Q4 		$11.3M Sell
2,250,252
-47,542
-2% -$209K 0.67% 32
2023
Q3 		$9.67M Buy
2,297,794
+895,914
+64% +$3.39M 0.83% 29
2023
Q2 		$5.65M Sell
1,401,880
-26,795
-2% -$93.7K 0.55% 48
2023
Q1 		$4.03M Buy
1,428,675
+1,155,944
+424% +$3.02M 0.31% 57
2022
Q4 		$4.19M Buy
+272,731
New +$1.02M 0.27% 54

Other funds holding ABEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OIA
OneDigital Investment Advisors Overland Park, Kansas $11.8B AUM 21.23% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nantahala Capital Management's ABEO Position: Q2 2026 in Review

Nantahala Capital Management increased its Abeona Therapeutics (ABEO) stake by 2.5% in Q2 2026, buying an estimated $678K and bringing the position to 5,136,490 shares worth $31.7M. The position accounts for 1.05% of the portfolio, ranked #22.

Nantahala Capital Management first reported a position in ABEO in Q4 2022 and has held it in 15 quarters since. 127 funds tracked by Wall St. Rank hold ABEO as of Q2 2026.

  • Nantahala Capital Management held 5,136,490 shares of Abeona Therapeutics worth $31.7M as of Q2 2026.
  • Nantahala Capital Management bought 123,438 Abeona Therapeutics shares in Q2 2026, an estimated $678K.
  • Abeona Therapeutics made up 1.05% of Nantahala Capital Management's portfolio in Q2 2026, its #22 holding.
  • Nantahala Capital Management first reported a position in Abeona Therapeutics in Q4 2022 and has held it in 15 quarters since.
  • 127 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2026.

Based on Nantahala Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.